These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 35152072)
21. A strategy of "adding fuel to the flames" enables a self-accelerating cycle of ferroptosis-cuproptosis for potent antitumor therapy. Huang L; Zhu J; Wu G; Xiong W; Feng J; Yan C; Yang J; Li Z; Fan Q; Ren B; Li Y; Chen C; Yu X; Shen Z Biomaterials; 2024 Dec; 311():122701. PubMed ID: 38981152 [TBL] [Abstract][Full Text] [Related]
22. Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer. Wu X; Xue X; Wang L; Wang W; Han J; Sun X; Zhang H; Liu Y; Che X; Yang J; Wu C Eur J Pharmacol; 2018 May; 827():1-12. PubMed ID: 29547841 [TBL] [Abstract][Full Text] [Related]
23. Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers. Chen W; Yang W; Chen P; Huang Y; Li F ACS Appl Mater Interfaces; 2018 Dec; 10(48):41118-41128. PubMed ID: 30444340 [TBL] [Abstract][Full Text] [Related]
24. Enhanced pH-Responsive Chemo/Chemodynamic Synergistic Cancer Therapy Based on In Situ Cu Zhou M; Tian B; Bu Y; Wu Z; Yu J; Wang S; Sun X; Zhu X; Zhou H ACS Appl Bio Mater; 2023 Aug; 6(8):3221-3231. PubMed ID: 37428493 [TBL] [Abstract][Full Text] [Related]
25. The disulfiram/copper complex induces apoptosis and inhibits tumour growth in human osteosarcoma by activating the ROS/JNK signalling pathway. Guo W; Zhang X; Lin L; Wang H; He E; Wang G; Zhao Q J Biochem; 2021 Oct; 170(2):275-287. PubMed ID: 33792698 [TBL] [Abstract][Full Text] [Related]
26. Turning anecdotal irradiation-induced anticancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells. Guo W; Jia L; Xie L; Kiang JG; Wang Y; Sun F; Lin Z; Wang E; Zhang Y; Huang P; Sun T; Zhang X; Bian Z; Tang T; Guo J; Ferrone S; Wang X Cell Death Dis; 2024 Apr; 15(4):298. PubMed ID: 38678042 [TBL] [Abstract][Full Text] [Related]
27. Hypoxia-Adapted Sono-chemodynamic Treatment of Orthotopic Pancreatic Carcinoma Using Copper Metal-Organic Frameworks Loaded with an Ultrasound-Induced Free Radical Initiator. Sun Y; Cao J; Wang X; Zhang C; Luo J; Zeng Y; Zhang C; Li Q; Zhang Y; Xu W; Zhang T; Huang P ACS Appl Mater Interfaces; 2021 Aug; 13(32):38114-38126. PubMed ID: 34357760 [TBL] [Abstract][Full Text] [Related]
28. Engineering Metal-Organic Framework Hybrid AIEgens with Tumor-Activated Accumulation and Emission for the Image-Guided GSH Depletion ROS Therapy. Dong MJ; Li W; Xiang Q; Tan Y; Xing X; Wu C; Dong H; Zhang X ACS Appl Mater Interfaces; 2022 Jul; 14(26):29599-29612. PubMed ID: 35737456 [TBL] [Abstract][Full Text] [Related]
29. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents. Kannappan V; Ali M; Small B; Rajendran G; Elzhenni S; Taj H; Wang W; Dou QP Front Mol Biosci; 2021; 8():741316. PubMed ID: 34604310 [TBL] [Abstract][Full Text] [Related]
30. Copper(II)-based metal-organic framework delivery of calcium ascorbate for enhanced chemodynamic therapy Zhang M; Xue H; Yang J; Zhao X; Xue M; Sun W; Qiu J; Zhu Z Biomater Sci; 2024 Mar; 12(7):1871-1882. PubMed ID: 38411574 [TBL] [Abstract][Full Text] [Related]
31. Disulfiram-loaded copper sulfide nanoparticles for potential anti-glioma therapy. Lan QH; Du CC; Yu RJ; Zhai J; Shi Y; Kou L; Xiao J; Lu CT; Zhao YZ; Yao Q Int J Pharm; 2021 Sep; 607():120978. PubMed ID: 34371152 [TBL] [Abstract][Full Text] [Related]
32. The combination of disulfiram and copper for cancer treatment. Li H; Wang J; Wu C; Wang L; Chen ZS; Cui W Drug Discov Today; 2020 Jun; 25(6):1099-1108. PubMed ID: 32320854 [TBL] [Abstract][Full Text] [Related]
33. Apoptosis and Paraptosis Induced by Disulfiram-Loaded Ca Guo Z; Gao X; Lu J; Li Y; Jin Z; Fahad A; Pambe NU; Ejima H; Sun X; Wang X; Xie W; Zhang G; Zhao L ACS Nano; 2024 Mar; 18(9):6975-6989. PubMed ID: 38377439 [TBL] [Abstract][Full Text] [Related]
34. Copper-Based Metal-Organic Framework Enables ROS Amplification and Drug Potency Activation. Zuo J; Hao S; Li W; Huang H; Liu M; Guo H Langmuir; 2023 Jun; 39(23):8008-8021. PubMed ID: 37234046 [TBL] [Abstract][Full Text] [Related]
35. A Tumor Microenvironment-Responsive Theranostic Agent for Synergetic Therapy of Disulfiram-Based Chemotherapy and Chemodynamic Therapy. Zhang H; Lv Z; Xue D; Zhang T; Jin L; Cao Y; Zhang S; Wang Y; Zhang H J Phys Chem Lett; 2021 Nov; 12(44):10880-10885. PubMed ID: 34730355 [TBL] [Abstract][Full Text] [Related]
36. Co-delivery of nanoparticle and molecular drug by hollow mesoporous organosilica for tumor-activated and photothermal-augmented chemotherapy of breast cancer. Zhang H; Song F; Dong C; Yu L; Chang C; Chen Y J Nanobiotechnology; 2021 Sep; 19(1):290. PubMed ID: 34579711 [TBL] [Abstract][Full Text] [Related]
37. The construction of hierarchical assemblies with Zhao WN; Li H; Sun S; Xu Y J Mater Chem B; 2023 Nov; 11(46):11044-11051. PubMed ID: 37904545 [TBL] [Abstract][Full Text] [Related]
38. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy. Zhang L; Tian B; Li Y; Lei T; Meng J; Yang L; Zhang Y; Chen F; Zhang H; Xu H; Zhang Y; Tang X ACS Appl Mater Interfaces; 2015 Nov; 7(45):25147-61. PubMed ID: 26501354 [TBL] [Abstract][Full Text] [Related]
39. Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells. Chen SY; Chang YL; Liu ST; Chen GS; Lee SP; Huang SM Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918312 [TBL] [Abstract][Full Text] [Related]
40. Photothermally Triggered Copper Payload Release for Cuproptosis-Promoted Cancer Synergistic Therapy. Zhou J; Yu Q; Song J; Li S; Li XL; Kang BK; Chen HY; Xu JJ Angew Chem Int Ed Engl; 2023 Mar; 62(12):e202213922. PubMed ID: 36585379 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]